We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.3B
AUM Growth
-$596M
Cap. Flow
-$1.62B
Cap. Flow %
-2.89%
Top 10 Hldgs %
32.29%
Holding
1,743
New
37
Increased
427
Reduced
443
Closed
34

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$374M
2
MSFT icon
Microsoft
MSFT
+$253M
3
AAPL icon
Apple
AAPL
+$200M
4
AVGO icon
Broadcom
AVGO
+$198M
5
META icon
Meta Platforms (Facebook)
META
+$193M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Financials 13.84%
3 Healthcare 12.35%
4 Consumer Discretionary 10.61%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRM icon
1551
Gentherm
THRM
$1.28B
$596K ﹤0.01%
14,929
SHC icon
1552
Sotera Health
SHC
$5B
$593K ﹤0.01%
43,362
CLDX icon
1553
Celldex Therapeutics
CLDX
$2.77B
$592K ﹤0.01%
23,428
CSGS
1554
DELISTED
CSG Systems International
CSGS
$591K ﹤0.01%
11,560
DGII icon
1555
Digi International
DGII
$2.54B
$581K ﹤0.01%
19,220
OSCR icon
1556
Oscar Health
OSCR
$9.21B
$578K ﹤0.01%
43,022
+4,100
+11% +$66K
TBPH icon
1557
Theravance Biopharma
TBPH
$875M
$573K ﹤0.01%
60,907
VERA icon
1558
Vera Therapeutics
VERA
$2.42B
$573K ﹤0.01%
13,550
+1,800
+15% +$79.7K
AUPH icon
1559
Aurinia Pharmaceuticals
AUPH
$1.93B
$572K ﹤0.01%
63,735
ARVN icon
1560
Arvinas
ARVN
$520M
$571K ﹤0.01%
29,770
+4,850
+19% +$118K
CNXC icon
1561
Concentrix
CNXC
$1.57B
$571K ﹤0.01%
13,187
MQ icon
1562
Marqeta
MQ
$1.91B
$571K ﹤0.01%
37,636
VIPS icon
1563
Vipshop
VIPS
$7.1B
$570K ﹤0.01%
42,350
SCL icon
1564
Stepan Co
SCL
$1.32B
$569K ﹤0.01%
8,802
INVX
1565
Innovex International
INVX
$1.82B
$569K ﹤0.01%
40,758
NAVI icon
1566
Navient
NAVI
$825M
$568K ﹤0.01%
42,733
ADNT icon
1567
Adient
ADNT
$1.67B
$567K ﹤0.01%
32,891
NGVT icon
1568
Ingevity
NGVT
$2.64B
$566K ﹤0.01%
13,894
MATW icon
1569
Matthews International
MATW
$901M
$566K ﹤0.01%
20,449
PHR icon
1570
Phreesia
PHR
$666M
$566K ﹤0.01%
22,491
PLRX icon
1571
Pliant Therapeutics
PLRX
$67.5M
$563K ﹤0.01%
42,768
MXL icon
1572
MaxLinear
MXL
$5.4B
$556K ﹤0.01%
28,112
RC
1573
Ready Capital
RC
$261M
$556K ﹤0.01%
81,470
XLB icon
1574
State Street Materials Select Sector SPDR ETF
XLB
$8.85B
$555K ﹤0.01%
+13,202
New +$611K
ACI icon
1575
Albertsons Companies
ACI
$5.67B
$550K ﹤0.01%
28,004
+22,315
+392% +$423K

Similar funds

Ensign Peak Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Ensign Peak Advisors held 1,743 positions worth $56.3B, down 1% from $56.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.1%. Ensign Peak Advisors opened 37 new positions and exited 34, leaving the 1,743-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 515,457 shares worth $302M.
  • Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $156M increase.
  • Ensign Peak Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $374M.
  • Ensign Peak Advisors fully exited NewAmsterdam Pharma in Q4 2024, selling an estimated $4.08M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.3B portfolio in Q4 2024.
  • Ensign Peak Advisors opened 37 new positions and closed 34 in Q4 2024.
  • Ensign Peak Advisors's portfolio value fell 1% quarter-over-quarter to $56.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.